Understanding Pancreatic Development and Diabetes Using Patient-Specific iPS Cells
.
Pancreatic progenitor cells derived from human embryonic stem or induced pluripotent stem cells hold tremendous potential for modeling pancreatic development and disease, as well as for regenerative therapies addressing degenerative conditions like diabetes. The ability to direct differentiation of pancreatic progenitor cells to specific endocrine cell types has led researchers to propose human pluripotent stem cells as an unlimited source of insulin-producing beta cells for studying and treating diabetes. In this webinar, Dr. Ray Dunn and Dr. Jamie Trott (A*STAR Institute for Medical Biology, Singapore) present their data on generating pancreatic progenitors and beta cells from diabetic-patient-derived induced pluripotent stem cells.
Publish Date:
April 18, 2016
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
Genome Editing From Modeling Disease to Novel Therapeutics
Publish Date: June 20, 2014 -
Investigating Metabolic Disease with Human Pluripotent Stem Cells
Publish Date: May 13, 2016 -
Making Lung Cells from Pluripotent Stem Cells: Disease Modeling and Future Therapies
Publish Date: August 12, 2016
Explore Our Products
-
STEMdiff™ Pancreatic Progenitor Kit
Serum-free medium for the differentiation of human ES and iPS cells to pancreatic progenitor cells -
STEMdiff™ Definitive Endoderm Kit
Defined animal component-free medium for the differentiation of human ES and iPS cells to definitive endoderm
